Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone versus prednisone as first-line therapy for newly diagnosed pediatric immune thrombocytopenic purpura
PACTR202403843973020Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Tanta University
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone and prednisone in immune thrombocytopenia (ITP), sponsored by Faculty of Medicine, Tanta University. Started Oct 2023; status: recruiting.
02
Drugs
dexamethasoneprednisone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on PACTR202403843973020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202403843973020.